0.4607
price up icon1.77%   0.008
after-market Handel nachbörslich: .44 -0.0207 -4.49%
loading
Schlusskurs vom Vortag:
$0.4527
Offen:
$0.46
24-Stunden-Volumen:
592.27K
Relative Volume:
2.55
Marktkapitalisierung:
$49.57M
Einnahmen:
$1.29M
Nettoeinkommen (Verlust:
$-29.87M
KGV:
-1.2797
EPS:
-0.36
Netto-Cashflow:
$-14.70M
1W Leistung:
-29.12%
1M Leistung:
-29.78%
6M Leistung:
-8.26%
1J Leistung:
-35.57%
1-Tages-Spanne:
Value
$0.4378
$0.4798
1-Wochen-Bereich:
Value
$0.4378
$0.67
52-Wochen-Spanne:
Value
$0.3951
$0.94

VolitionRX Ltd Stock (VNRX) Company Profile

Name
Firmenname
VolitionRX Ltd
Name
Telefon
646 650 1351
Name
Adresse
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Name
Mitarbeiter
37
Name
Twitter
@VolitionRx
Name
Nächster Verdiensttermin
2025-08-18
Name
Neueste SEC-Einreichungen
Name
VNRX's Discussions on Twitter

Vergleichen Sie VNRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
VNRX
VolitionRX Ltd
0.4607 48.71M 1.29M -29.87M -14.70M -0.36
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
525.83 198.09B 43.21B 6.58B 6.17B 17.28
Diagnostics & Research icon
DHR
Danaher Corp
206.15 146.89B 24.01B 3.41B 4.86B 4.7082
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
636.91 50.67B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
138.04 39.19B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
204.76 34.64B 15.70B 1.24B 2.01B 6.9036

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-08 Eingeleitet H.C. Wainwright Buy
2023-02-01 Herabstufung The Benchmark Company Buy → Hold
2022-02-17 Fortgesetzt Cantor Fitzgerald Overweight
2021-03-10 Eingeleitet Cantor Fitzgerald Overweight
2018-05-16 Eingeleitet Maxim Group Buy
2018-05-14 Bestätigt The Benchmark Company Buy
2016-09-07 Bestätigt Rodman & Renshaw Buy
2016-02-01 Eingeleitet Rodman & Renshaw Buy
Alle ansehen

VolitionRX Ltd Aktie (VNRX) Neueste Nachrichten

pulisher
12:23 PM

Can VolitionRX Limited stock sustain free cash flowGDP Growth & Safe Capital Growth Plans - newser.com

12:23 PM
pulisher
Oct 13, 2025

Published on: 2025-10-13 09:58:07 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 06:57:47 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Does VolitionRx Limited show high probability of reboundEntry Point & Free Technical Confirmation Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

VolitionRx prices $6 million public offering of common stock and warrants By Investing.com - Investing.com South Africa

Oct 10, 2025
pulisher
Oct 10, 2025

VolitionRx (VNRX) Sets Pricing for Public Offering of Shares and Warrants - GuruFocus

Oct 10, 2025
pulisher
Oct 10, 2025

VolitionRx Prices Public Offering Of 11.55 Mln Shares And Warrants At $0.52/set; Shares Fall - Nasdaq

Oct 10, 2025
pulisher
Oct 10, 2025

$6.0M Gross Proceeds — VolitionRx Prices 11.55M Shares & Warrants; Close Expected Oct 14, 2025 - Stock Titan

Oct 10, 2025
pulisher
Oct 10, 2025

Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday - Benzinga

Oct 10, 2025
pulisher
Oct 09, 2025

VolitionRx (VNRX) Plans Public Offering to Bolster Development a - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

VolitionRx announces proposed public offering of common stock By Investing.com - Investing.com Australia

Oct 09, 2025
pulisher
Oct 09, 2025

Volitionrx stock tumbles on proposed public offering By Investing.com - Investing.com South Africa

Oct 09, 2025
pulisher
Oct 09, 2025

Volitionrx stock tumbles on proposed public offering - Investing.com India

Oct 09, 2025
pulisher
Oct 09, 2025

VolitionRx announces offering of common stock and warrants, no amount given - TipRanks

Oct 09, 2025
pulisher
Oct 09, 2025

15% Overallotment Option: VolitionRx Proposes Underwritten Offering of Common Stock & Warrants - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Live market analysis of VolitionRx LimitedJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

VolitionRx Limited Stock Analysis and ForecastPrice Momentum Alerts & Build Diversified Portfolios With Ease - earlytimes.in

Oct 07, 2025
pulisher
Oct 03, 2025

Is VolitionRx Limited a candidate for recovery playFed Meeting & Reliable Price Action Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will a bounce in VolitionRx Limited offer an exit2025 Macro Impact & Real-Time Volume Analysis - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is VolitionRX Limited stock resilient in recession scenariosJuly 2025 Setups & Weekly High Return Forecasts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Will VolitionRX Limited stock boost dividends furtherNew Guidance & Accurate Buy Signal Notifications - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Beyond the Genome: Volition Showcases Revolutionary Nu.Q Platform for Epigenetic Drug Discovery - Stock Titan

Oct 02, 2025
pulisher
Oct 01, 2025

VolitionRX (NYSEAMERICAN:VNRX) Trading 9% HigherShould You Buy? - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50 By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

VolitionRX (VNRX) Receives Reiterated Buy Rating by HC Wainwrigh - GuruFocus

Sep 30, 2025
pulisher
Sep 30, 2025

Why analysts remain bullish on VolitionRx Limited stockQuarterly Trade Report & Safe Entry Zone Tips - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

VolitionRx Partners with Hologic to Expand Access to Epigenetic Testing Services for Drug Developers - citybuzz

Sep 29, 2025
pulisher
Sep 29, 2025

VNRX Stock: Analyst Maintains 'Buy' Rating with $5.00 Price Targ - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

What indicators show strength in VolitionRx Limited2025 Volume Leaders & Verified Entry Point Signals - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

$200M Market Opportunity: Volition Teams with $4B Healthcare Giant Hologic for Epigenetic Testing Service - Stock Titan

Sep 29, 2025
pulisher
Sep 26, 2025

What drives VolitionRx Limited stock priceEx-Dividend Date Alerts & Free Popular Stock Picks Selection - earlytimes.in

Sep 26, 2025
pulisher
Sep 25, 2025

Institutional scanner results for VolitionRx LimitedGlobal Markets & Accurate Trade Setup Notifications - newser.com

Sep 25, 2025
pulisher
Sep 24, 2025

News impact scoring models applied to VolitionRx LimitedJuly 2025 Summary & Expert Approved Trade Ideas - newser.com

Sep 24, 2025
pulisher
Sep 23, 2025

Understanding VolitionRx Limited’s price movementWeekly Trade Analysis & Reliable Trade Execution Plans - newser.com

Sep 23, 2025
pulisher
Sep 22, 2025

Using Python tools to backtest VolitionRx Limited strategiesMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Real time pattern detection on VolitionRx Limited stock2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com

Sep 22, 2025
pulisher
Sep 20, 2025

VolitionRX Limited (NYSEAMERICAN:VNRX) Sees Large Growth in Short Interest - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

How to monitor VolitionRx Limited with trend dashboardsIndex Update & Precise Buy Zone Tips - newser.com

Sep 20, 2025
pulisher
Sep 19, 2025

How to use a screener to detect VolitionRx Limited breakoutsJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Signal strength of VolitionRx Limited stock in tech scannersMarket Growth Summary & Stock Portfolio Risk Control - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Bear Alert: What is the long term forecast for VolitionRx Limited stockMarket Rally & Long-Term Growth Plans - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Will VolitionRx Limited bounce back from current supportJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com

Sep 18, 2025
pulisher
Sep 17, 2025

Aug Breakouts: Whats the MACD signal for VolitionRx Limited2025 Short Interest & Technical Confirmation Alerts - خودرو بانک

Sep 17, 2025

Finanzdaten der VolitionRX Ltd-Aktie (VNRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research WAT
$333.14
price down icon 0.95%
diagnostics_research DGX
$185.39
price up icon 1.43%
diagnostics_research LH
$279.78
price up icon 1.14%
$172.81
price down icon 0.78%
diagnostics_research MTD
$1,303.04
price up icon 1.42%
diagnostics_research IQV
$204.76
price up icon 0.49%
Kapitalisierung:     |  Volumen (24h):